Synthesis and evaluation of novel 1,5-benzodiazepines as potent and selective CCK-B ligands. Effect of the substitution of the N-5 phenyl with alkyl groups

被引:11
作者
Finizia, G
Donati, D
Oliosi, B
Tranquillini, ME
Ursini, A
机构
[1] Glaxo Wellcome S.p.A., Medicines Research Center, 37135 Verona
关键词
D O I
10.1016/S0960-894X(96)00544-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation of both 3-ureido and 3-carbamate derivatives of 1,5-benzodiazepines bearing bulky alkyl substituents at N-1 and N-5 positions is reported. Their activity as CCK-B receptor antagonists is discussed and compared with the related N-5-phenyl derivatives. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:2957 / 2962
页数:6
相关论文
共 23 条
[1]  
CORSI M, 1995, BRIT J PHARMACOL, V114, pP91
[2]   BIOLOGICAL ACTIONS OF CHOLECYSTOKININ [J].
CRAWLEY, JN ;
CORWIN, RL .
PEPTIDES, 1994, 15 (04) :731-755
[3]   A NEW METHOD FOR THE RESOLUTION OF AMINES AND ITS APPLICATION TO 3-AMINO-1,5-BENZODIAZEPINES [J].
CUROTTO, G ;
DONATI, D ;
FINIZIA, G ;
URSINI, A .
TETRAHEDRON-ASYMMETRY, 1995, 6 (04) :849-852
[4]   1,5-benzodiazepines as CCK-B antagonists. Effect of halogen substitution at the benzo-fused ring on potency and selectivity. [J].
Curotto, G ;
Donati, D ;
Pentassuglia, G ;
Ursini, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (24) :3011-3016
[5]   CHOLECYSTOKININ ANTAGONISTS - A TOXICOLOGIC PERSPECTIVE [J].
DETHLOFF, LA ;
DELAIGLESIA, FA .
DRUG METABOLISM REVIEWS, 1992, 24 (02) :267-293
[6]  
FERIANI A, 1995, Patent No. 2280182
[7]  
FERIANI A, 1993, Patent No. 14074
[8]  
FINIZIA G, 1995, P 2 C CONG IT SPAGN
[9]  
GAVIRAGHI G, 1995, P 10 CAM NOORDW S PE
[10]   CCK IN ANIMAL AND HUMAN RESEARCH ON ANXIETY [J].
HARRO, J ;
VASAR, E ;
BRADWEJN, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (06) :244-249